01 August 2007
Risks and benefits of open-lung biopsy in the mechanically ventilated critically ill population: A cohort study and literature review
Yaseen Arabi, Raees Ahmed, Qanta Ahmed, Masood Ur Rahman, Nizar YamaniMed Sci Monit 2007; 13(8): CR365-371 :: ID: 491653
Abstract
Background: The study’s objective was to determine the diagnostic yield, morbidity, mortality, and therapeutic impact of open-lung biopsy (OLB) in mechanically ventilated, critically ill patients.
Material/Methods: The study was conducted as a retrospective cohort study in multidisciplinary ICU in a tertiary level academic center and included all patients with respiratory failure and diffuse pulmonary infiltrates who underwent OLB between 1996-2004. Patient demographics, presenting symptoms, co-morbidities, APACHEII and SAPS II scores, and the diagnostic work-up preceding OLB were recorded. Pre- and post-biopsy PaO[sub]2[/sub]/FiO[sub]2[/sub] ratios, lung compliance, and PEEP were documented. The impact of histological diagnosis on the management was determined. Operative complications including bleeding, intraoperative hemodynamic instability, and persistent air leak were also reviewed.
Results: Fourteen patients were identified. The median ventilator time before OLB was 8.5 days. Nine patients were on inotropes and seven on renal replacement therapy at the time of biopsy. PaO[sub]2[/sub]/FiO[sub]2[/sub] ratio, lung compliance, and PEEP levels pre- and post-biopsy were not significantly different. Histological diagnoses were established in all 14 patients. Biopsy results led to the addition of a new therapy in 9 patients (64%) and the withdrawal of unnecessary therapy in 2 patients (14%). No major perioperative or intraoperative complications occurred. Six (43%) patients were discharged alive from the hospital.
Conclusions: Open-lung biopsy in mechanically ventilated critically ill patients provides significant diagnostic information leading to change in the management of the majority of patients. The procedure is well tolerated and associated with an acceptable benefit-to-risk ratio.
Keywords: Risk, Respiratory System - pathology, Respiration, Artificial, Lung Diseases - surgery, Lung - pathology, Cohort Studies, Biopsy - methods, Risk, Respiratory System - pathology, Respiration, Artificial, Lung Diseases - surgery, Lung - pathology, Cohort Studies, Biopsy - methods
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin SecretionMed Sci Monit In Press; DOI: 10.12659/MSM.945224
Database Analysis
Role of the Carhart Effect and Outcomes from Surgery: A Retrospective Study of 532 Patients with Conductive...Med Sci Monit In Press; DOI: 10.12659/MSM.947061
Clinical Research
Factors Affecting Medication Adherence in Middle-Aged and Elderly Patients in China: A Cross-Sectional StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945805
Review article
Characteristics and Associated Risk Factors of Broad Ligament Hernia: A Systematic ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.946710
Most Viewed Current Articles
17 Jan 2024 : Review article 6,963,278
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 700,194
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,571
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 18,228
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912